Viridian Therapeutics, Inc. (VRDN)
$18.22-0.44%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.6B
- Beta
- 0.96
- P/E (TTM)
- -5.16
- Short % float
- 24.35%
- Days to cover
- 8.9
- SI change
- -7.7%
- 1W
- +0.00%
- 1M
- -17.93%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- -20.43%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VRDN?
- LOPJLB’s latest quantitative signal on Viridian Therapeutics, Inc. (VRDN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is VRDN in?
- Viridian Therapeutics, Inc. (VRDN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Viridian Therapeutics, Inc. (VRDN) do?
- Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclonal anti-IGF-1R antibody currently advancing through Phase 1/2 clinical trials for thyroid eye disease (TED). The company's portfolio also features VRDN-002, an IGF-1R antibody undergoing Phase 1 cli…